Ohtsuki H, Morita K, Minami N, Suemitsu T, Tsujimoto A, Dohi T
Department of Pharmacology, Hiroshima University, School of Dentistry, Japan.
Neurochem Int. 1992 Sep;21(2):259-67. doi: 10.1016/0197-0186(92)90156-l.
Catecholamine (CA) release from adrenal medulla evoked by muscarinic receptor stimulation has been studied using isolated perfused adrenal gland and cultured chromaffin cells from dogs. Muscarine and oxotremorine (1-100 microM), and bethanechol (0.1-1 mM) dose-dependently stimulated CA release. Muscarine-evoked CA release was antagonized with M1-antagonist, pirenzepine and, to a lesser extent, with atropine; and was reduced either by removal of extracellular Ca2+ or treatment with Ca2+ channel blockers. Muscarine caused an increase of 45Ca uptake and 22Na uptake. Tetrodotoxin (TTX) did not affect muscarine-evoked increase of 22Na uptake and CA release. Under the absence of extracellular Ca2+, muscarine stimulated a 45Ca efflux. Muscarine-induced CA release was attenuated by treating the cells with 8-(N,N-diethylamino)-octyl-3,4,5-trimethoxybenzoate-HCl (TMB-8) which blocks Ca2+ release from the intracellular store. A phospholipase C inhibitor, neomycin, markedly reduced muscarine-induced CA release but not nicotine- and high K(+)-evoked release. Cinnarizine, a Ca2+ channel blocker, attenuated muscarine-evoked but not caffeine-induced CA release and 45Ca efflux in the absence of extracellular Ca2+. Muscarine caused an increase in intracellular free Ca2+ concentration ([Ca2+]i) in the presence of extracellular Ca2+. It caused a similar increase, but to a lesser extent, in the absence of extracellular Ca2+. The increase of [Ca2+]i induced by muscarine without extracellular Ca2+ was reduced by neomycin and cinnarizine. Polymixin B and retinal, which reduced 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced CA release, had little effect on muscarine-induced CA release. Muscarine increased cellular Ins(1,4,5)P3 production, and atropine inhibited this increase.(ABSTRACT TRUNCATED AT 250 WORDS)
利用狗的离体灌注肾上腺和培养的嗜铬细胞,研究了毒蕈碱受体刺激引起的肾上腺髓质儿茶酚胺(CA)释放。毒蕈碱、氧化震颤素(1 - 100微摩尔)和氨甲酰甲胆碱(0.1 - 1毫摩尔)剂量依赖性地刺激CA释放。毒蕈碱引起的CA释放被M1拮抗剂哌仑西平拮抗,且在较小程度上被阿托品拮抗;通过去除细胞外Ca2+或用Ca2+通道阻滞剂处理可使其减少。毒蕈碱导致45Ca摄取和22Na摄取增加。河豚毒素(TTX)不影响毒蕈碱引起的22Na摄取增加和CA释放。在无细胞外Ca2+的情况下,毒蕈碱刺激45Ca外流。用8 -(N,N - 二乙氨基) - 辛基 - 3,4,5 - 三甲氧基苯甲酸 - HCl(TMB - 8)处理细胞可减弱毒蕈碱诱导的CA释放,TMB - 8可阻断Ca2+从细胞内储存库释放。磷脂酶C抑制剂新霉素显著降低毒蕈碱诱导的CA释放,但不影响尼古丁和高钾引起的释放。钙通道阻滞剂桂利嗪在无细胞外Ca2+时减弱毒蕈碱诱导的CA释放,但不影响咖啡因诱导的CA释放和45Ca外流。在有细胞外Ca2+存在时,毒蕈碱导致细胞内游离Ca2+浓度([Ca2+]i)增加。在无细胞外Ca2+时,它也引起类似增加,但程度较小。新霉素和桂利嗪可减少毒蕈碱在无细胞外Ca2+时诱导的[Ca2+]i增加。多粘菌素B和视黄醛可减少12 - O - 十四烷酰佛波醇 - 13 - 乙酸酯(TPA)诱导的CA释放,但对毒蕈碱诱导的CA释放影响很小。毒蕈碱增加细胞内肌醇(1,4,5)三磷酸(Ins(1,4,5)P3)的产生,阿托品可抑制这种增加。(摘要截短于250字)